Last updated on: 7/8/2014 | Author: ProCon.org

Steven Patierno, PhD Biography

Title:
Deputy Director of the Duke Cancer Institute and Professor of Medicine at Duke University School of Medicine
Position:
Pro to the question "Should Marijuana Be a Medical Option?"
Reasoning:

“The use of marijuana as a medicine is remarkably uncontroversial at the bedside of a cancer patient or a child suffering from convulsions who might be helped…

The Compassionate Care Act, passed by the New York State Legislature last month and signed into law by Gov. Andrew Cuomo on July 5, [2014], introduces simple yet profound reforms by banning marijuana smoking and mandating individual dosing of medical cannabis in all other forms, such as capsules and vaporization. By treating medical marijuana like other medicines, New York shifted the debate into the mainstream of modern medicine and set a much-needed national standard of care…

Metered dosing is the standard of care in modern medicine, allowing doctors to prescribe precise amounts based on the patient’s response, and reducing the chance of adverse drug interactions…

Cannabis produced in metered doses is easily tested for contaminants, and the potency of all active ingredients, for instance, and sterilized for safety—essential public-health safeguards…

[T]he introduction of smokeless cannabis in dosage form will immediately ease human pain and suffering and help to move medical marijuana from the underground economy to the mainstream of the nation’s health-care system.”

“New York Does Medical Marijuana Right,” Wall Street Journal, July 7, 2014

Theoretical Expertise Ranking:
    Experts
Individuals with MDs, PhDs, JDs, or equivalent advanced degrees in fields relevant to medical marijuana. Also top-level government officials (such as foreign leaders, US presidents, Founding Fathers, Supreme Court Justices, members of legislative bodies, cabinet members, military leaders, etc.) with positions relevant to medical marijuana issues.
Involvement and Affiliations:
  • Deputy Director, Duke Cancer Institute, 2012-present
  • Professor, Medicine, Duke University School of Medicine
  • Professor, Pharmacology, Cancer Biology, Community and Family Medicine, Duke University
  • Executive Director, George Washington University Cancer Institute, 1988-2012
  • Founding Director, Molecular and Cellular Oncology PhD Program, George Washington University Medical Center
  • Former Vivian Gill Distinguished Professor of Oncology, George Washington University
  • Former Professor of Pharmacology, Genetics, and Urology, School of Medicine and Health Sciences, George Washington University
  • Former Professor of Environmental and Occupational Health, George Washington University School of Public Health and Health Services
  • Post-doctoral fellow, University of Southern California Norris Comprehensive Cancer Center, 1985-1988
  • Former Rosalie B. Hite Graduate Fellowship, Cancer Research, MD Anderson Cancer Institute.
  • Recipient, Distinguished Public Service Award, Breast Cancer Resource Committee
  • Recipient, Stoddard Community Service Award, Family and Child Services of Washington, DC
  • Education:
  • PhD, Pharmacology and Molecular Oncology, Graduate School of Biomedical Science, University of Texas Health Science Center, 1985
  • BS, Pharmacy, University of Connecticut, 1981
  • Other:
  • Has authored over 100 scientific journal articles and book chapters